Simplex Trading
KYNB

Simplex Trading’s Kyntra Bio KYNB Stock Holding History

Simplex Trading’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,932
Closed -$14K – 8962
2025
Q1 		$14K Buy
1,932
+12
+0.6% +$144 ﹤0.01% 6838
2024
Q4 		$25K Sell
1,920
-108
-5% -$1K ﹤0.01% 6503
2024
Q3 		$20K Sell
2,028
-796
-28% -$12K ﹤0.01% 6666
2024
Q2 		$62K Buy
2,824
+1,296
+85% +$40K ﹤0.01% 5855
2024
Q1 		$89K Buy
+1,528
New +$65.8K ﹤0.01% 5703
2023
Q3 		– Sell
-5,828
Closed -$393K – 8992
2023
Q2 		$393K Buy
5,828
+5,344
+1,104% +$2.21M ﹤0.01% 3557
2023
Q1 		$225K Sell
484
-60
-11% -$31.7K ﹤0.01% 4184
2022
Q4 		$217K Sell
544
-616
-53% -$236K ﹤0.01% 4129
2022
Q3 		$377K Buy
1,160
+700
+152% +$225K ﹤0.01% 3801
2022
Q2 		$121K Sell
460
-52
-10% -$13.3K ﹤0.01% 5293
2022
Q1 		$153K Buy
512
+468
+1,064% +$163K ﹤0.01% 5542
2021
Q4 		$15K Sell
44
-1,808
-98% -$563K ﹤0.01% 8673
2021
Q3 		$1.23M Buy
1,852
+16
+0.9% +$5.67K ﹤0.01% 2792
2021
Q2 		$1.22M Buy
1,836
+1,834
+91,700% +$1.06M ﹤0.01% 2825
2021
Q1 		$180K Sell
2
-18
-90% -$19.2K ﹤0.01% 4899
2020
Q4 		$1.83M Buy
20
+13
+186% +$13.7K ﹤0.01% 1865
2020
Q3 		$694K Sell
7
-7
-50% -$7.53K ﹤0.01% 2643
2020
Q2 		$1.4M Sell
14
-7
-33% -$6.5K ﹤0.01% 1824
2020
Q1 		$1.81M Sell
21
-21
-50% -$20.9K ﹤0.01% 1356
2019
Q4 		$4.52M Buy
42
+28
+200% +$28.6K 0.01% 867
2019
Q3 		$1.25M Sell
14
-4
-22% -$4.39K ﹤0.01% 1728
2019
Q2 		$2.06M Buy
18
+5
+38% +$5.47K 0.01% 1293
2019
Q1 		$1.75M Hold
13
– – ﹤0.01% 1491
2018
Q4 		$1.55M Sell
13
-18
-58% -$20.2K ﹤0.01% 1272
2018
Q3 		$4.7M Buy
31
+14
+82% +$21.6K 0.02% 657
2018
Q2 		$2.69M Buy
17
+1
+6% +$1.3K 0.01% 939
2018
Q1 		$311K Hold
16
– – 0.01% 969
2017
Q4 		$141K Sell
16
-8
-33% -$10K 0.01% 1542
2017
Q3 		$149K Buy
24
+14
+140% +$14.8K 0.01% 1408
2017
Q2 		$69K Buy
10
+4
+67% +$2.79K ﹤0.01% 2077
2017
Q1 		$106K Buy
6
+5
+500% +$3.04K ﹤0.01% 1700
2016
Q4 		$9K Sell
1
-1
-50% -$499 ﹤0.01% 3834
2016
Q3 		$24K Sell
2
-2
-50% -$942 ﹤0.01% 2786
2016
Q2 		$46K Buy
+4
New +$1.83K ﹤0.01% 2135
2015
Q4 		– Sell
-2
Closed -$9K – 5601
2015
Q3 		$9K Buy
+2
New +$1.21K ﹤0.01% 3533

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Simplex Trading's KYNB Position: Q1 2025 in Review

Simplex Trading sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 1,540 shares — an estimated $18.5K sold.

Simplex Trading first reported a position in KYNB in Q2 2016 and held it in 30 quarters. The position peaked at $2.48M in Q2 2021. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.

  • Simplex Trading reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 1,540 Kyntra Bio shares in Q1 2025, an estimated $18.5K.
  • Simplex Trading first reported a position in Kyntra Bio in Q2 2016 and held it in 30 quarters.
  • Simplex Trading's Kyntra Bio position peaked at $2.48M in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.